- Home
- ZSQR vs TLRY Comparison
ZSQR vs TLRY Comparison
Compare ZSQR & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZSQR | TLRY |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 697.4M | 570.4M |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ZSQR | TLRY |
|---|---|---|
| Price | $4.87 | $4.53 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $72.33 |
| AVG Volume (30 Days) | 552.0K | ★ 4.3M |
| Earning Date | N/A | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.79 |
| Revenue Next Year | N/A | $19.98 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.32 | $0.57 |
| 52 Week High | $16.62 | $15.70 |
Technical Indicators
Market Signals| Indicator | ZSQR | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 30.81 | 48.48 |
| Support Level | $4.34 | $4.20 |
| Resistance Level | $8.79 | $4.85 |
| Average True Range (ATR) | 0.84 | 0.19 |
| MACD | 0.23 | 0.04 |
| Stochastic Oscillator | 28.14 | 75.29 |
Price Performance
Historical ComparisonAbout ZSQR Z Squared Inc. Common Stock
Z Squared Inc is a computing infrastructure company operating computing equipment and expanding into AI infrastructure. The Company's idea is to build on three principles: guide with power by acquiring operating sites where power is already flowing; build for AI workloads by converting that capacity into AI-ready colocation where the customer brings the compute and runs what it needs; and scale with discipline by deploying conversion capital site by site, against signed contracts and operational readiness.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.